Prayer of the Epileptologist
|
|
- Albert Hodges
- 5 years ago
- Views:
Transcription
1 Prayer of the Epileptologist Lord, grant that my work increase knowledge and help other men. Failing that, Lord, grant that it will not lead to man's destruction. Failing that, Lord, grant that my article in Epilepsia be published before the destruction takes place. Walker Percy
2 Epilepsy in Long Term Care Patients Old Concepts and New Data Amir Arain, M.D. Vanderbilt University
3 Long term care patients Patients with mental retardation and developmental disability Geriatric patients
4
5 Seizures in Patients with MR/DD 1/5 th of the population of intellectually disabled have epilepsy Incidence greatly varies with epidemiological methods. In this population, there is a high incidence of confounding nonepileptic events Uncontrolled seizures effect the life of individuals and care takers alike regardless of intellectual disability
6 Epilepsy, Concomitant Cerebral Palsy, and Severity of MR In several studies epilepsy risk has been positively correlated with severity of MR Jacobson et al 1983: N= % had MR Epilepsy in 23% and CP in 16% Epilepsy in 9% of mild MR and 43% of severe MR CP in 9% of mild MR and 29% of severe MR
7 Types of Seizures In population based studies GTC most common Forsgren et al 1990 Institution based studies CPS +/- GTC most common Mariani et al 1993 Tonic, atonic, myoclonic and atypical absence seizures are also seen. Seizure types are age related GTC and CPS predominate at later ages
8 Seizure classification ILAE classification is not easily applicable to mentally retarded epileptic patients < 34% could classified by Mansford et al 1992 < 28% could classified by Mariani et al 1993
9 Tonic seizures
10
11 Atonic seizures
12 Differential diagnosis 2/3 rd institutionalized patients with intellectual disability have stereotypical behavior e.g. head movements, rocking and jerking Berkson & Davenport 1962 Medication side effects e.g. tardive dyskinesia can mimic seizure Paul 1997
13 Morbidity Several factors have an impact on the caring of intellectually disabled individual Maladaptive behavior Severity of intellectual disability Presence of multiple disabilities Level of social support
14 Maladaptive behavior & psychiatric disorder Espie at al found people with double disability showed poor life skills than peers Aggression & self injurious behavior strongly associated with frequent seizures and antiepileptic polytherapy.
15 Morbidity of the Care-givers 108 children with epilepsy, presence of intellectual disability had a significant impact on caregivers Hoare 1993 Carers experience stress and prone to clinical anxiety & depression Espie et al (1998)
16 Physical morbidity Intellectually disabled have high incidence of vitamin D deficiency (Wageman et al 1998) Concomitant use of antiepileptic medication can be an additional factor Intellectually disabled with epilepsy have a much higher rate of fracture.
17 Mortality Patients with epilepsy have increased risk of mortality Patients with intellectual disability have increased risk of mortality The risk of mortality is even higher in epilepsy patients with intellectual disability
18 Seizures provoking factors Fever Infection Constipation Noncompliance with medications Medications side effects
19 Treatment: General principles Several factors, besides seizures, need special attention Therapy should not focus solely on seizure freedom. These patients already have limited quality of life that needs to be preserved and enhanced.
20 Cognitive Side effects Investigation/treatment hampered by lack of communication CNS side effects of antiepileptic drugs may be masked. Drowsiness, mood change and behavioral problems may represent toxicity Side effects may manifest as behavioral problem Devinsky 1995
21 Antiepileptic medications Drug compliance Cooperation difficulties, swallowing difficulty Drugs available as liquid, in soluble form, as powder or as granular may be useful Rectal suppository and IV formulation Caregivers are extremely important In mild MR drug dispensers & alarm watches
22 Worsening of Seizures Some AEDs may have paradoxical effect Can be due to overdose or specific effect Phenytoin encephalopathy can manifest as frequent seizures Iivanainen 1987 Carbamazepine can worsen symptomatic atypical absence Lerman 1986 GTC seizures Snead and Hosey, 1985
23 Worsening of Seizures Benzodiazepines can worsen tonic seizures in Lennox- Gastaut syndrome. Homan et al 1997 Vigabatrin can worsen absence, myoclonic, tonic and GTC seizures Lamictal may worsen severe myoclonic epilepsy of infancy Guerrini et al 1998 Many AEDs may cause enhanced aggressiveness & violence in MR patients Beran &Gibson, 1998
24 Treatment Alvarez (1989) suggested AED withdrawal after 2 yrs. N= 50 Recurrence of seizures 26 patients 52% 11 patients had recurrence during withdrawal 80% of discontinuation happened <3yrs.
25 Predictors of successful discontinuation History of few documented seizures No gross neurological abnormalities Non therapeutic levels at discontinuation Persistent normal EEG pre and post discontinuation
26 Surgical treatment An IQ< 70 was considered a relative contraindication for surgical treatment Engel 1993 If the seizure onset is focal from a brain lesion resective surgery should be considered irrespective of the IQ. In older patients the chances for multiple epileptogenic lesions is high Early intervention may prevent worsening
27
28 Geriatric Epilepsy
29 Hauser WA. Epilepsia Age-Specific Incidence of Epilepsy by Gender in Rochester, Minnesota:
30 Incidence of unprovoked seizures and epilepsy in Iceland Incidence of all unprovoked seizures by age in Iceland from 1995 to 1999 DrElias Olafsson et al Lancet Neurol Oct;4(10):627-34
31 Epilepsy in the Elderly Epilepsy cases rise sharply after age 60 Incidence at age 50 years is ~ 28/100,000/yr Incidence at 60 years is 40/100,000/yr Incidence at 75 years is 139/100,000/yr
32 Demographics Different for younger people with epilepsy
33 Elderly (>65 years) Incidence of Alzheimer's 123/100,000 Incidence of Epilepsy 134/100,000 Olmsted County Data
34 Epilepsy in the Elderly: Incidence and Etiology
35 Factors Associated With an Altered Risk of Epilepsy Family history of seizures 2.5 Severe military head trauma 580 Severe civillian head trauma 25 Moderate head trauma 4 Mild head trauma Stroke 1.5 * 22 Viral encephalitis 16.2 Alzheimer's disease 10 Bacterial meningitis Multiple sclerosis Aseptic meningitis Alcohol 10.1 Heroin Marijuana No adverse exposure Adapted with permission from Hauser WA, Hesdorffer DC. Epilepsy Foundation of America Relative Altered Risk *Not statistically significant.
36 Epilepsy in the Elderly: Seizure Type Complex Partial 38% Generalized Tonic-Clonic 27% Simple Partial 14% Mixed 20% VA Co-op 2003 n=593
37 Epilepsy in the Elderly: Concurrent diseases Hypertension 64% Stroke 53% Cardiac Disease 49% Diabetes 27% History of Cancer 22% VA Co-op 2003 n=593
38 Epilepsy in the Elderly: Imaging Normal 18% CVA 44% Small vessel disease 40% Diffuse atrophy 35% Encephalomalacia 9% VA Co-op 2003 n=593
39 Epilepsy in the Elderly: EEG Normal 31% Epileptiform 39% Focal Slow 40% Generalized Slow 16% VA Co-op 2003 n=593
40 Stroke As A Cause Of Epilepsy Annual Incidence of Stroke (Williams, 2001) 750,000 in U.S. (1996) Seizures after Stroke Cooperative Study (Bladin, 2000) Prospective, 9-month follow-up, n=2021 Seizures in 8.9% 2.3% recurrent seizures
41 Table 1: Risk Factors for Developing Seizures Patients Patients with without seizures, seizures, n (%) n (%) Significanceª Type of stroke Ischemic 13 (7) 170 (93) Hemorrhagic 9 (25) 27 (75) 0.01 Location of lesion Cortical Subcortical 16 (17) 77 (83) 6 (4.7) 120 (95.3) 0.01 Size of lesion Large Small 14 (21.2) 52 (78.8) 8 (5.2) 145 (94.8) 0.01 ª Chi-square.
42 Table 2: Time Between Symptomatic Supratentorial Brain Infarct and First Seizure in 58 of 65 Patients with Postinfarct Epilepsy, Registered in the MECR (in seven times of stroke not certified). Seizure Delay Number Percentage of Patients <2 weeks 14 24% >2 weeks - <1 Year 22 38% >1 year - <2 years 11 19% >2 years 11 19%
43 Table 3: Infarct Types on CT in 38 Patients With Epileptic Seizures After Symptomatic Supratentorial Brain Infarction Infarct Type Number of Patients (%) Cortical infarct(s) only* 28 (73.7) Lacunar infarcts(s) only 6 (15.8) Cortical and lacunar infarct 2 (5.3) Cortical and striatocapsular infarct 1 (2.6) Cortical and watershed infarct 1 (2.6) * Six had two infarcts Three had two infarcts, one had seven infarcts
44 Seizures in Alzheimers Autopsy verified, n=81 10% had seizures Hauser, 1986
45 Epilepsy in the Elderly Epilepsy in the elderly is often misdiagnosed
46
47
48
49
50
51 Delay In Diagnosis VA Co-op Subset (n=167), months to seek medical attention 1.7 years to correct diagnosis GTC: immediate diagnosis in 67% Less dramatic seizures often ignored Concomitant cardiac or cerebrovascular disease caused delays in diagnosis Spitz, et al
52 Diagnosis of Epilepsy: Elderly Compared to Younger People Higher percentage of partial seizures More extra-temporal onset complex partial seizures (missing classic auras) More prominent post-ictal symptoms Weaker historians EEG less helpful More concomitant illnesses
53 Some Diagnostic Dilemmas GTC vs. syncope Complex partial seizure vs. TIA Transient Global Amnesia
54 GTC Compared to Syncope GTC Syncope History of Cardiac Disease Common Common Positional Variable Orthostatic Warning Variable Pre-syncope Tongue biting Common Unlikely Complexion Normal Pale After Event Confused, sleepy Alert Movements Tonic-clonic Loss of tone, brief clonic movements Duration 1-2 minutes seconds to then post-ictal minutes Incontinence varies varies
55 Complex Partial Seizures Compared to TIA CPS TIA Hx of CV Disease Common Common Anatomic distribution Not Vascular Vascular Confusion, unresponsiveness Present Absent (may be aphasic) Frequency Can be frequent Rarely frequent Amnesia Common Absent Aura Common Absent Automatisms Common Absent
56 Treat or not to Treat The risk of recurrence of seizures is about 30-35% after the first unprovoked seizure The risk of recurrence is about 70% after second seizure Recurrence rate in elderly
57 Epilepsy in the Elderly: Pharmacokinetics and Drug Interactions
58 70% of new onset Epilepsy patients were first seen by nonneurologists
59 Determinants of Quality of Life in Patients with Epilepsy Relationship Between Seizure Frequency and Quality of Life QOLIE-89 Total Score n = 195 (r =.01, P =.93) Average Monthly Seizure Rate Gilliam F. Neurology. 2002;58(suppl 5):S9-S19. Reprinted with permission.
60 Determinants of Quality of Life in Patients with Epilepsy Relationship Between Adverse Events and Quality of Life QOLIE-89 Total Score n = 195 (partial correlation r =.061, P <.001) Adverse Event Profile Score Gilliam F. Neurology. 2002;58(suppl 5):S9-S19. Reprinted with permission.
61 Pharmacokinetic overview of classical AEDs PHT CBZ VPA PHB PMD ESX CZP Bioavailability >90% 75-85% >90% >90% >90% >90% >80% Protein binding 90% 75% 90% 45% <20% <10% 86% % Metabolism 95% >95% >96% <80% Metabolism site Liver Liver Liver Liver Liver Liver Liver T1/ Autoinduction no yes no no no no no
62 Are AED Pharmacokinetics and Drug Interactions in the Elderly Important Issues? Medication use is greatest in old age Older AEDs are frequently prescribed to elderly 1,2 AED efficacy and safety profiles differ from younger patients Pharmacokinetics change with age Greater risk of drug interactions 1. Lackner, Cloyd et al. Epilepsia. 1998;39: Nitz NM, Garrard J, et al, AES, 2000;41(suppl 7):215
63 Co-Medication Use in Elderly Nursing Home Residents on AEDs Drug Category Antidepressants Antipsychotics Benzodiazepines 12.7% 19% 22% Thyroid Supplements Antacids Antiepileptic Drugs Calcium Channel Blockers Warfarin Cimetidine 0 14% 8% 12% 7% 5.9% 2.5% Lackner, Cloyd et al, Epilepsia 39: , Maintenance Medication Use by Elderly Nursing Home Residents + AED AED 6 meds 5 meds % of Antiepileptic Drug Recipients
64 AED Efficacy and Safety in the Elderly Elderly Appear more responsive to AED therapy at lower concentrations Have an increased risk of adverse reactions
65 Physiological Changes of Aging Affecting AED Pharmacokinetics in GI anatomy variable absorption Serum albumin altered protein binding Hepatic blood flow Liver Mass Oxidative reactions ( 1%/yr 40 yrs) or conjugation reactions? Induction of microsomal enzymes? Glomerular filtration ( 1%/yr 40 yrs) Disease may exacerbate physiologic changes However, there are few AED pharmacokinetic studies in the elderly, esp. oldest-old ( 85)
66 AED Pharmacokinetics in the Elderly: Protein Binding Several AEDs are highly bound to serum proteins, primarily albumin - Carbamazepine 75-85%* - Valproate 80-95% Phenytoin 90% - Tiagabine 96% * CBZ binds to both albumin and alpha 1 acid glycoprotein (AAG) Changes in protein binding cause misleading measurement of total concentration of highly bound AEDs Cloyd, 1998.
67 Use of AED ER Formulations in the Elderly Elderly are at greater risk for noncompliance due to # of medications and cognitive impairment Elderly may be more susceptible Cmax-related side effects, particularly from rapidly absorbed AEDs ER formulations may Enhance compliance by reducing dosing frequency Improve therapeutic outcomes Decrease peak-related side effects Improved efficacy with higher blood levels Decrease nursing medication administration time
68 Isoenzyme-Mediated AED Metabolism and Drug Interactions AED Substrates Inhibitors Inducers CYP 1A2 CYP 2C9 CYP 2C19 CYP 3A4* UGT CBZ (minor) PHT Diazepam PB PHT (minor) VPA (minor) Cimetidine Ciprofloxacin Enoxacin Fluvoxamine Tacrine Ticlopidine Cigarette smoke Omeprazole Charbroiled meats Amiodarone Cimetidine Felbamate Fluconazole Fluoxetine Fluvastatin Isoniazid Losartan Ticlopidine CBZ Rifampin St. John s wort Fluvoxamine OXC, MHD (weak) Omeprazole Ticlopidine TPM Dexamethasone Phenytoin Phenobarbital Rifampin Rifapentine St. John s wort CBZ epoxidation Clonazepam Diazepam Felbamate Ethosuximide Midazolam Tiagabine ZNS Azole antifungals (eg, ketoconazole) Cimetidine Erythromycin Clarithromycin Diltiazem HIV Protease Inhibitor Fluoxetine Grapefruit juice Nefazodone Sertraline (weak) CBZ PHT PB Rifampin Rifapentine Rifabutin St. John s wort Lorazepam Lamotrigine MHD VPA VPA CBZ LMT PB PHT Rifampin OCs (LMT) * CYP3A4: catalyzes biotransformation of 50% of all drug undergoing metabolism
69 Relationship of PHT Half-Life with Age Age (years Cloyd et al, 2004
70 Phenytoin-Simulated Dosing Requirements in Elderly vs Younger Adults Phenytoin Concentration (mg/l) Differences in PHT Content: Capsules 92% Infatabs 100% Suspension 100% Time to SS = 3-5 wk Daily Dose (mg/kg) as PHT Acid 8 Elderly (60-79 y) 1 Vmax = 5.5 mg/kg/d Km = 5.8 mg/l Adults (19-64 y) 2 Vmax = 8.45 mg/kg/d Km = 6.25 mg/l Bauer and Blouin. Clin Pharmacol Ther. 1982;31: Cloyd et al. Epilepsy International Symposium Vancouver, Canada.
71 Effect of Age on Total Plasma Valproate Concentrations 6 young, 6 elderly volunteers 400 mg dose Total Plasma VPA (Ìmol/L) Total Plasma Valproate Concentrations Free Fraction 6% 11% Time (h) Perucca et al. Br J Clin Pharmacol. 1984;17:
72 Effect of Age on Unbound VPA Concentrations Free Plasma VPA (Ìmol/L) Unbound Plasma Valproate Concentrations Free Fraction 6% 11% Time (h) Perucca et al. Br J Clin Pharmacol. 1984;17:
73 Pharmacokinetics of Newer AEDs Drug Absorption Binding Elimination T 1/2 (hr) Interactions* GBP 60% 0% 100% renal 5-9 No LTG 100% 55% 100% hepatic Uni-D LVT ~100% <10% 66% renal 4-8 No OXC/MHD 100% 40% 100% hepatic 5-11 Bi-D PGB 90% 0% 100% renal 5-7 No TGB ~100% 96% 100% hepatic 5-13 Yes TPM 80% 15% 30%-55% renal Bi-D ZNS 80%-100% 40%-60% 50%-70% hepatic Uni-D In noninduced adult; Saturable; Binding, elimination, and t 1/2 refer to MHD; *Bi-D=bidirectional; Uni-D=unidirectional. Adapted from Cloyd JC, Remmel RP. Pharmacotherapy. 2000;20:139S-151S.
74 Effect of CBZ on Serum Simvastastin and Simvastatin Acid Concentrations Ucar et al, EJCP, 2004
75 Effect of Grapefruit Juice on Drug Metabolism
76 Inhibition of CYP 3A4 by Grapefruit Juice: Effect on Carbamazepine Serum Levels CBZ + Grapefruit juice CBZ CBZ Concentration (mg/l) Time (hours) Garg et al. Clin Pharmacol Ther. 1998;64:
77 Potent inducer of CYP 3A enzymes
78 Herbs and Epilepsy Herbs may increase the risk for seizures: intrinsic proconvulsant properties contamination by heavy metals effects on the cytochrome P450 enzymes and P- glycoproteins, herb drug interactions
79
80 Epilepsy Treatment in the Elderly Monotherapy is possible for 90%+ of patients. Typical nursing home patient is on 6-8 medications. Choose AEDs with minimal interactions e.g. levetiracetam, pregabalin and gabapentin Titrate slowly Avoid older AEDs with strong induction effects (phenytoin, phenobarbital, and carbamazepine) Avoid newer AEDs with established adverse cognitive effects (topiramate and zonisamide)
81 Topiramate and Zonisamide 94% of patients experienced cognitive viscosity with either drug as an adjunctive agent* 63% of the patients were unaware of the effect* Lee S, Sziklas V, Andermann, et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia, Vol 44, No 3, 2003:
82 Oxcarbazepine and Tiagabine Oxcarbazepine can result in hyponatremia much more commonly in elderly Tiagabine has been associated with encephalopathy
83 Older AEDs and the Elderly Inducing drugs: phenytoin, carbamazepine and phenobarbital result in consequences Behavioral Cognitive Valproate - weight gain, risk of encephalopathy. Can be used, but carefully. Phenobarbitol can have significant cognitive slowing, depression, or other behavioral consequences
84 80% of 21,435 pts. received phenobarbital or phenytoin. Most patients were taking phenytoin 18.9% of patients with previously diagnosed epilepsy 9.4% of patients with newly diagnosed epilepsy received phenobarbital White veterans Patients receiving neurology consultation were half as likely to receive phenytoin monotherapy. J Am Geriatr Soc Mar;52(3):
85 Epilepsy in long term care patients Not rare Demographics different than normal intelligence people Often misdiagnosed Can be treated with monotherapy Side effects are more common Use new seizure medications
86 Questions & Answers
87 Thank you for your attention.
Epilepsy and EEG in Clinical Practice
Mayo School of Professional Development Epilepsy and EEG in Clinical Practice November 10-12, 2016 Hard Rock Hotel at Universal Orlando Orlando, FL Course Directors Jeffrey Britton, MD and William Tatum,
More informationSlide 1. Slide 2. Slide 3. Objectives. Why should we care about the elderly? Antiseizure Drugs in Elderly Patients
Slide 1 Antiseizure Drugs in Elderly Patients Angela Birnbaum, Ph.D. Professor Epilepsy Research and Education Program Center for Clinical and Cognitive Neuropharmacology College of Pharmacy University
More informationEPILEPSY: SPECTRUM OF CHANGE WITH AGE. Gail D. Anderson, Ph.D.
EPILEPSY: SPECTRUM OF CHANGE WITH AGE Gail D. Anderson, Ph.D. Incidence: 0.5% - 1.0% of U.S. population Peak incidence of onset: first 2 years of life, ages 5-7 years, early puberty and elderly. 125,000
More informationEpilepsy and Epileptic Seizures
Epilepsy and Epileptic Seizures Petr Marusič Dpt. of Neurology Charles University, Second Faculty of Medicine Motol University Hospital Diagnosis Steps Differentiation of nonepileptic events Seizure classification
More informationErnie Somerville Prince of Wales Hospital EPILEPSY
Ernie Somerville Prince of Wales Hospital EPILEPSY Overview Classification New and old anti-epileptic drugs (AEDs) Neuropsychiatric side-effects Limbic encephalitis Non-drug therapies Therapeutic wishlist
More informationEpilepsy is a very individualized
... PRESENTATION... Treatment of Epilepsy in 3 Specialized Populations Based on a presentation by Ilo E. Leppik, MD Presentation Summary When discussing the treatment of epilepsy, targeted populations
More informationEpilepsy 7/28/09! Definitions. Classification of epilepsy. Epidemiology of Seizures and Epilepsy. International classification of epilepsies
Definitions Epilepsy Dr.Yotin Chinvarun M.D., Ph.D. Seizure: the clinical manifestation of an abnormal and excessive excitation of a population of cortical neurons Epilepsy: a tendency toward recurrent
More informationEpilepsy T.I.A. Cataplexy. Nonepileptic seizure. syncope. Dystonia. Epilepsy & other attack disorders Overview
: Clinical presentation and management Markus Reuber Professor of Clinical Neurology Academic Neurology Unit University of Sheffield, Royal Hallamshire Hospital. Is it epilepsy? Overview Common attack
More informationEpilepsy. Annual Incidence. Adult Epilepsy Update
Adult Epilepsy Update Annual Incidence J. Layne Moore, MD, MPH Associate Professor Department of Neurology and Pharmacy Director, Division of Epilepsy The Ohio State University Used by permission Health
More informationDisclosures. AED Options. Epilepsy Pharmacotherapy: Treatment Considerations with Older AEDs
Epilepsy Pharmacotherapy: Treatment Considerations with Older AEDs BARRY E. GIDAL, PHARMD PROFESSOR SCHOOL OF PHARMACY & DEPT. OF NEUROLOGY Disclosures Speaking honoraria: UCB, Eisai, Sunovion Consultant:
More informationAED Treatment Approaches. David Spencer, MD Director, OHSU Epilepsy Center Professor, Department of Neurology
AED Treatment Approaches David Spencer, MD Director, OHSU Epilepsy Center Professor, Department of Neurology Audience Response Keypads Please utilize the keypad at your table to answer questions throughout
More informationPharmacological Treatment of Non-Lesional Epilepsy December 8, 2013
Pharmacological Treatment of Non-Lesional Epilepsy December 8, 2013 Michael Privitera, MD Professor of Neurology University of Cincinnati, Neuroscience Institute American Epilepsy Society Annual Meeting
More informationPrescribing and Monitoring Anti-Epileptic Drugs
Prescribing and Monitoring Anti-Epileptic Drugs Mark Granner, MD Clinical Professor and Vice Chair for Clinical Programs Director, Iowa Comprehensive Epilepsy Program Department of Neurology University
More informationWhen choosing an antiepileptic ... PRESENTATION... Pharmacokinetics of the New Antiepileptic Drugs. Based on a presentation by Barry E.
... PRESENTATION... Pharmacokinetics of the New Antiepileptic Drugs Based on a presentation by Barry E. Gidal, PharmD Presentation Summary A physician s choice of an antiepileptic drug (AED) usually depends
More informationUpdate in Clinical Guidelines in Epilepsy
Why We Need Clinical Guidelines? Clinician needs advice! Update in Clinical Guidelines in Epilepsy Charcrin Nabangchang, M.D. Phramongkutklao College of Medicine Tiamkao S, Neurology Asia2013 Why We Need
More informationDifficult to treat childhood epilepsy: Lessons from clinical case scenario
Difficult to treat childhood epilepsy: Lessons from clinical case scenario Surachai Likasitwattanakul, M.D. Department of Pediatrics Faculty of Medicine, Siriraj Hospital Natural history of Epilepsy Untreated
More informationObjectives. Amanda Diamond, MD
Amanda Diamond, MD Objectives Recognize symptoms suggestive of seizure and what those clinical symptoms represent Understand classification of epilepsy and why this is important Identify the appropriate
More informationIntroduction to seizures and epilepsy
Introduction to seizures and epilepsy Selim R. Benbadis, M.D. Professor Departments of Neurology & Neurosurgery Director, Comprehensive Epilepsy Program Symptomatic seizures Head injury (trauma) Stroke
More informationTherapeutic strategies in the choice of antiepileptic drugs
Acta neurol. belg., 2002, 102, 6-10 Original articles Therapeutic strategies in the choice of antiepileptic drugs V. DE BORCHGRAVE, V. DELVAUX, M. DE TOURCHANINOFF, J.M. DUBRU, S. GHARIANI, Th. GRISAR,
More informationDisclosure. Learning Objectives
Linda D. Leary, M.D. Associate Clinical Professor of Pediatrics & Neurology South Texas Comprehensive Epilepsy Center UT Health Science Center San Antonio Disclosure Linda D. Leary, M.D. discloses the
More information7/31/09. New AEDs. AEDs. Dr. Yotin Chinvarun M.D. Ph.D. Comprehensive Epilepsy and Sleep disorder Program PMK hospital. 1 st genera*on AEDs
Dr. Yotin Chinvarun M.D. Ph.D. Comprehensive Epilepsy and Sleep disorder Program PMK hospital New AEDs AEDs NEW OLD Pregabalin Pregabalin 1 st genera*on AEDs Phenytoin Carbamazepine Valproate Phenobarbital
More informationChildren Are Not Just Small Adults Choosing AEDs in Children
Children Are Not Just Small Adults Choosing AEDs in Children Natrujee Wiwattanadittakun, MD Neurology division, Department of Pediatrics, Chiang Mai University Hospital, Chiang Mai University 20 th July,
More informationNeuromuscular Disease(2) Epilepsy. Department of Pediatrics Soochow University Affiliated Children s Hospital
Neuromuscular Disease(2) Epilepsy Department of Pediatrics Soochow University Affiliated Children s Hospital Seizures (p130) Main contents: 1) Emphasize the clinical features of epileptic seizure and epilepsy.
More informationAnticonvulsants Antiseizure
Anticonvulsants Antiseizure Seizure disorders Head trauma Stroke Drugs (overdose, withdrawal) Brain tumor Encephalitis/ Meningitis High fever Hypoglycemia Hypocalcemia Hypoxia genetic factors Epileptic
More informationManagement of Epilepsy in Primary Care and the Community. Carrie Burke, Epilepsy Specialist Nurse
Management of Epilepsy in Primary Care and the Community Carrie Burke, Epilepsy Specialist Nurse Epilepsy & Seizures Epilepsy is a common neurological disorder characterised by recurring seizures (NICE,
More informationMeasures have been taken, by the Utah Department of Health, Bureau of Health Promotions, to ensure no conflict of interest in this activity
Measures have been taken, by the Utah Department of Health, Bureau of Health Promotions, to ensure no conflict of interest in this activity Seizures in the School Setting Meghan Candee, MD MS Assistant
More informationAN UPDATE ON ANTIEPILEPTIC AGENTS: FOCUS ON AN UPDATE ON ANTIEPILEPTIC AGENTS: FOCUS ON SECOND GENERATION TREATMENT OPTIONS
Volume 24, Issue 1 October 2008 AN UPDATE ON ANTIEPILEPTIC AGENTS: FOCUS ON SECOND GENERATION TREATMENT OPTIONS Jason Richey, Pharm.D. Candidate Epilepsy is a neurological disorder characterized by sudden
More informationThe primary goal of antiepileptic drug
THE ROLE OF THERAPEUTIC DRUG MONITORING IN PATIENT CARE * Page B. Pennell, MD ABSTRACT The dose-response relationship for antiepileptic drugs (AEDs) varies enormously between and within individual patients.
More informationAPPENDIX K Pharmacological Management
1 2 3 4 APPENDIX K Pharmacological Management Table 1 AED options by seizure type Table 1 AED options by seizure type Seizure type First-line AEDs Adjunctive AEDs Generalised tonic clonic Lamotrigine Oxcarbazepine
More informationIn our patients the cause of seizures can be broadly divided into structural and systemic causes.
Guidelines for the management of Seizures Amalgamation and update of previous policies 7 (Seizure guidelines, ND, 2015) and 9 (Status epilepticus, KJ, 2011) Seizures can occur in up to 15% of the Palliative
More informationEpilepsy 101. Overview of Treatment Kathryn A. O Hara RN. American Epilepsy Society
Epilepsy 101 Overview of Treatment Kathryn A. O Hara RN American Epilepsy Society Objectives Describe the main treatment options for epilepsy Identify factors essential in the selection of appropriate
More informationIs it epilepsy? Does the patient need long-term therapy?
Is it a seizure? Definition Transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain Is it provoked or unprovoked? Is it epilepsy? Does the
More informationARTICLES Monotherapy in adults and elderly persons
ARTICLES Monotherapy in adults and elderly persons Edward Faught, MD Address correspondence and reprint requests to Dr. Edward Faught, Department of Neurology, University of Alabama at Birmingham Epilepsy
More informationHow to choose/use anti-epileptic drugs wisely? Dr. Chusak Limotai, MD., M.Sc., CSCN(C)
How to choose/use anti-epileptic drugs wisely? Dr. Chusak Limotai, MD., M.Sc., CSCN(C) Talk overview When to start treatment? Which drug? Monotherapy Combining AEDs (Rational polytherapy) Old AEDs versus
More informationReview of Anticonvulsant Medications: Traditional and Alternative Uses. Andrea Michel, PharmD, CACP
Review of Anticonvulsant Medications: Traditional and Alternative Uses Andrea Michel, PharmD, CACP Objectives Review epidemiology of epilepsy Classify types of seizures Discuss non-pharmacologic and pharmacologic
More informationTalk outline. Some definitions. Emergency epilepsy now what? Recognising seizure types. Dr Richard Perry. Management of status epilepticus
Emergency epilepsy now what? Dr Richard Perry Imperial College NHS Trust Imperial College Talk outline Recognising seizure types Management of status epilepticus Some definitions Epileptic seizure A clinical
More informationUpdated advice for nurses who care for patients with epilepsy
NICE BULLETIN Updated advice for nurses who care for patients with epilepsy NICE provided the content for this booklet which is independent of any company or product advertised NICE BULLETIN Updated advice
More informationEpilepsy in the Primary School Aged Child
Epilepsy in Primary School Aged Child Deepak Gill Department of Neurology and Neurosurgery The Children s Hospital at Westmead CHERI Research Forum 15 July 2005 Overview The School Age Child and Epilepsy
More informationInitial Treatment of Seizures in Childhood
Initial Treatment of Seizures in Childhood Roderic L. Smith, MD, Ph.D. Pediatric Neurology Clinic of Alaska,PC Incidence of Seizures Overall 5% by age 20 yrs. Lifetime risk= 5-10% CNS Infections= 5% TBI=10%
More informationNew Onset of Epilepsy in the Elderly Dec 6, 2013
New Onset of Epilepsy in the Elderly Dec 6, 2013 Ilo E. Leppik, MD Professor of Neurology and Pharmacy University of Minnesota American Epilepsy Society Annual Meeting Disclosure During my almost 40 years
More informationOn completion of this chapter you should be able to: list the most common types of childhood epilepsies and their symptoms
9 Epilepsy The incidence of epilepsy is highest in the first two decades of life. It falls after that only to rise again in late life. Epilepsy is one of the most common chronic neurological condition
More informationEpilepsy. Seizures and Epilepsy. Buccal Midazolam vs. Rectal Diazepam for Serial Seizures. Epilepsy and Seizures 6/18/2008
Seizures and Epilepsy Paul Garcia, M.D. UCSF Epilepsy Epileptic seizure: the physical manifestation of aberrant firing of brain cells Epilepsy: the tendency to recurrent, unprovoked epileptic seizures
More informationValproate Case 1: Pharmacokinetics Jose de Leon, MD
Valproate Case 1: Pharmacokinetics 2-12-16 Jose de Leon, MD 1. Valproate Case 1 J Clin Psychopharmacology 2009;29:509-11 http://www.ncbi.nlm.nih.gov/pubmed/19745660 Educational Objectives At the conclusion
More informationEpilepsy Medications: The Basics
Epilepsy Medications: The Basics B R I A N A P P A V U, M D C L I N I C A L A S S I S T A N T P R O F E S S O R, D E P A R T M E N T O F C H I L D H E A L T H A N D N E U R O L O G Y, U N I V E R S I T
More informationChapter 31-Epilepsy 1. public accountant, and has begun treatment with lamotrigine. In which of the following activities
Chapter 31-Epilepsy 1 Chapter 31. Epilepsy, Self-Assessment Questions 1. BW is a 28-year-old man recently diagnosed with partial seizures. He works as a certified public accountant, and has begun treatment
More informationTreatment of epilepsy in adults
Treatment of epilepsy in adults Review 33 Treatment of epilepsy in adults S B Gunatilake 1, A Arasalingam 2 Sri Lanka Journal of Neurology, 2012, 1, 33-38 Case vignettes 1. A 60-year old patient with long
More informationQuetiapine Case 2 Therapeutic Drug Monitoring Jose de Leon, MD
Quetiapine Case 2 Therapeutic Drug Monitoring 1-27-16 Jose de Leon, MD 2. Quetiapine Case Therapeutic Drug Monitoring (unpublished) Educational Objectives At the conclusion of this presentation, the participant
More informationCase 1: Issues in this case. Generalized Seizures. Seizure Rounds with S.Khoshbin M.D. Disclosures: NONE
Disclosures: NONE Seizure Rounds with S.Khoshbin M.D. Case 1: 45 yo male while jogging with his wife stopped,acted strangely for a while then fell to the ground and had a convulsion.emt s were called by
More information11/7/2018 EPILEPSY UPDATE. Dr.Ram Sankaraneni. Disclosures. Speaker bureau LivaNova
EPILEPSY UPDATE Dr.Ram Sankaraneni Disclosures Speaker bureau LivaNova 1 Outline New onset Seizure Investigations in patients with epilepsy Medical management of epilepsy Non Pharmacological options in
More informationCrackCast Episode 18 Seizures
CrackCast Episode 18 Seizures Episode overview: 1) Define status epilepticus 2) List the doses of common medications used for status epilepticus 3) List 10 differential diagnoses for seizures 4) List 10
More informationObjectives / Learning Targets: The learner who successfully completes this lesson will be able to demonstrate understanding of the following concepts:
Boone County Fire District EMS Education-Paramedic Program EMS 270 Medical Cases-Seizures Resources Seizures screencast Seizures Flowchart and Seizures Flowchart Video Explanation Objectives / Learning
More informationEpilepsy: problems of diagnosis and recommended treatment Nicola Cooper MRCP and Morgan Feely MD, FRCP, FRCP(I)
Epilepsy: problems of diagnosis and recommended treatment Nicola Cooper MRCP and Morgan Feely MD, FRCP, FRCP(I) VM Our series Prescribing in gives practical advice for successful management of the special
More informationEpilepsy the Essentials
INSTITUTE OF NEUROLOGY DCEE / NSE Epilepsy the Essentials Fergus Rugg-Gunn Consultant Neurologist Dept of Clinical and Experimental Epilepsy Institute of Neurology, University College London Epilepsy Society
More informationLevetiracetam in patients with generalised epilepsy and myoclonic seizures: An open label study
Seizure (2006) 15, 214 218 www.elsevier.com/locate/yseiz CASE REPORT Levetiracetam in patients with generalised epilepsy and myoclonic seizures: An open label study Angelo Labate a,b, Eleonora Colosimo
More informationIntroduction. 1 person in 20 will have an epileptic seizure at some time in their life
Introduction 1 person in 20 will have an epileptic seizure at some time in their life Epilepsy is diagnosed on the basis of two or more epileptic seizures. Around 450,000 people in the UK have epilepsy
More informationTailoring therapy to optimize care for Epilepsy. Dr Tim Wehner National Hospital for Neurology and Neurosurgery London, UK For discussion only
Tailoring therapy to optimize care for Epilepsy Dr Tim Wehner National Hospital for Neurology and Neurosurgery London, UK For discussion only Disclosures Session (travel expenses) sponsored by Pfizer Premature
More informationValproate Case 3: Formulations Jose de Leon, MD
Valproate Case 3: Formulations 2-12-16 Jose de Leon, MD 3.Valproate Case 3 Described in J Clin Psychiatry 2004;65:724-5 http://www.ncbi.nlm.nih.gov/pubmed/15163266 Pharmacological explanation provided
More informationChronic Management of Idiopathic Generalized epilepsies (IGE) Hassan S.Hosny M.D. Prof of Neurology, Cairo University
Chronic Management of Idiopathic Generalized epilepsies (IGE) Hassan S.Hosny M.D. Prof of Neurology, Cairo University Sanaa 2009 Points of Discussion Prevalence compared to focal epilepsy Adult form Status
More informationDiagnosing Epilepsy in Children and Adolescents
2019 Annual Epilepsy Pediatric Patient Care Conference Diagnosing Epilepsy in Children and Adolescents Korwyn Williams, MD, PhD Staff Epileptologist, BNI at PCH Clinical Assistant Professor, Department
More informationDosing & Administration
Dosing & Administration REAL LIFE. REAL RESULTS. INDICATION INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of: Schizophrenia. Schizoaffective disorder as monotherapy and as an
More informationIDENTIFYING TARGET POPULATIONS & DESIGNING CLINICAL TRIALS FOR ANTIEPILEPTOGENESIS. Ettore Beghi Istituto Mario Negri, Milano ITALY
IDENTIFYING TARGET POPULATIONS & DESIGNING CLINICAL TRIALS FOR ANTIEPILEPTOGENESIS Ettore Beghi Istituto Mario Negri, Milano ITALY OUTLINE Definitions & background risks in epilepsy End-points Target populations
More informationAMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY, INC. SUBSPECIALTY CERTIFICATION EXAMINATION IN EPILEPSY MEDICINE
SUBSPECIALTY CERTIFICATION EXAMINATION IN EPILEPSY MEDICINE 2014 Content Blueprint (November 26, 2012) Number of questions: 200 I. Classification 7 9% II. Routine EEG 16 20% III. Evaluation 22 26% IV.
More informationEpilepsy 2005 ILAE Report
1 Seizure & Epilepsy Care Gregory Krauss, MD Johns Hopkins University October 31, 2016 1 Epilepsy 2005 ILAE Report Seizure = a symptom Defined as paroxysmal change in behavior due to abnormal electrical
More informationEpilepsy management What, when and how?
Epilepsy management What, when and how? J Helen Cross UCL-Institute of Child Health, Great Ormond Street Hospital for Children, London, & National Centre for Young People with Epilepsy, Lingfield, UK What
More information1/31/2009. Paroxysmal, uncontrolled electrical discharge of neurons in brain interrupting normal function
Paroxysmal, uncontrolled electrical discharge of neurons in brain interrupting normal function In epilepsy abnormal neurons undergo spontaneous firing Cause of abnormal firing is unclear Firing spreads
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Absence seizures, 6 in childhood, 95 Adults, seizures and status epilepticus in, management of, 34 35 with first-time seizures. See Seizure(s),
More informationI. Introduction Epilepsy is the tendency to have recurrent seizures unprovoked by systemic or acute neurologic insults. Antiepileptic drugs (AEDs)
1 2 I. Introduction Epilepsy is the tendency to have recurrent seizures unprovoked by systemic or acute neurologic insults. Antiepileptic drugs (AEDs) are those which decrease the frequency and/or severity
More informationUnderstanding and Managing Epilepsy
Page 1 Understanding and Managing Epilepsy Jacquelyn L. Bainbridge, Pharm.D., FCCP Associate Professor University of Colorado Denver School of Pharmacy & Department of Neurology Supported by an educational
More information2018 American Academy of Neurology
Practice Guideline Update Efficacy and Tolerability of the New Antiepileptic Drugs I: Treatment of New-Onset Epilepsy Report by: Guideline Development, Dissemination, and Implementation Subcommittee of
More informationPaediatric Epilepsy Update N o r e e n Te a h a n canp C o l e t t e H u r l e y C N S E p i l e p s y
Paediatric Epilepsy Update 2018 N o r e e n Te a h a n canp C o l e t t e H u r l e y C N S E p i l e p s y Epilepsy Service CUH ~550 children New diagnosis-education, support, clinic follow up Epilepsy
More informationNewer AEDs compared to LVT as adjunctive treatments for uncontrolled focal epilepsy. Dr. Yotin Chinvarun. M.D. Ph.D.
Newer AEDs compared to LVT as adjunctive treatments for uncontrolled focal epilepsy Dr. Yotin Chinvarun. M.D. Ph.D. Chronology of antiepileptic drug introduction over the past 150 years 20 15 10 Perampanel
More informationTopics. What are Prediction Factors? Seizure type Etiologies Frequency of seizures Response to first AED Genetic?
Early Recognition and Management of Refractory Epilepsy Topics How to predict who developed refractory epilepsy Associate Professor Somsak Tiamkao Division of Neurology, Department of Medicine Faculty
More informationSUBSPECIALTY CERTIFICATION EXAMINATION IN EPILEPSY MEDICINE Content Blueprint (December 21, 2015)
SUBSPECIALTY CERTIFICATION EXAMINATION IN EPILEPSY MEDICINE 2016 Content Blueprint (December 21, 2015) Number of questions: 200 1. Classification 8-12% 2. Routine EEG 16-20% 3. Evaluation 23-27% 4. Management
More informationEpilepsy in dementia. Case 1. Dr. Yotin Chinvarun M..D. Ph.D. 5/25/16. CEP, PMK hospital
Epilepsy in dementia Dr. Yotin Chinvarun M..D. Ph.D. CEP, PMK hospital Case 1 M 90 years old Had a history of tonic of both limbs (Lt > Rt) at the age of 88 years old, eye rolled up, no grunting, lasting
More informationManagement of Epilepsy In Primary Care Practice. Video Examples. Talk Like a Neurologist: Seizure Types
Management of Epilepsy In Primary Care Practice S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Vice Chairman, Department of Neurology Director,
More informationThe epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care
The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care Issued: January 2012 guidance.nice.org.uk/cg137 NHS Evidence has accredited the process
More informationHormones & Epilepsy 18/07/61. Hormones & Women With Epilepsy (WWE) How different are women? Estradiol = Proconvulsant. Progesterone = Anticonvulsant
How different are women? AED choice in special population Women With Epilepsy (WWE) Updated 2018 Habitus Metabolism Co-morbidities Pasiri Sithinamsuwan Psychosocial stigma Phramongkutklao Hospital Hormonal
More informationNew AEDs in Uncontrolled seizures
New AEDs in Uncontrolled seizures Uncontrolled seizures/epilepsy Intractable epilepsy, Refractory epilepsy, Pharmacoresistant epilepsy Dr. Suthida Yenjun Traditionally, referred to therapeutic failure
More information8/30/10. How to use Antiepileptic drugs properly. 3nd generation AEDs. Introduction. Introduction. Introduction. AEDs. Dr.Yotin Chinvarun M.D., Ph.D.
Introduction How to use Antiepileptic drugs properly Modern treatment of seizures started in 1850 with the introduction of bromides, based on the theory that epilepsy was caused by an excessive sex drive
More informationEpilepsy: pharmacological treatment by seizure type. Clinical audit tool. Implementing NICE guidance
Epilepsy: pharmacological treatment by seizure type Clinical audit tool Implementing NICE guidance 2012 NICE clinical guideline 137 Clinical audit tool: Epilepsy (2012) Page 1 of 25 This clinical audit
More informationXournals. The Use Antiepileptic Drug (AED) during Pregnancy. Surya Kiran Sharma 1. Abstract: Authors:
ISSN UA Volume 01 Issue 01 June-2018 The Use Antiepileptic Drug (AED) during Pregnancy Surya Kiran Sharma 1 Available online at: www.xournals.com Received 13 th December 2017 Revised 15 th February 2018
More informationEPILEPSY DIAGNOSIS. Investigations- EEG, MRI, CT, blood tests. Appendix 1 contains a guide to questions to help with diagnosis
EPILEPSY DIAGNOSIS All adults with a recent-onset suspected seizure should be seen urgently by a specialist. The seizure type(s) and epilepsy syndrome, aetiology and co-morbidity should be determined.
More information62 yo F, RHD Epilepsy onset: 44 yo Seizure type: 1) Dyscognitive seizure 2) Somatosensory aura (abnormal feeling at both feet) Seizures disappeared
62 yo F, RHD Epilepsy onset: 44 yo Seizure type: 1) Dyscognitive seizure 2) Somatosensory aura (abnormal feeling at both feet) Seizures disappeared since age 56 years Seizure period: 12 years (44 56 yrs)
More informationDr. Chusak Limotai, MD., M.Sc., CSCN (C) Chulalongkorn Comprehensive Epilepsy Center of Excellence (CCEC)
Dr. Chusak Limotai, MD., M.Sc., CSCN (C) Chulalongkorn Comprehensive Epilepsy Center of Excellence (CCEC) Patients with hepatic or renal dysfunction Elderly patients Pregnant patients Psychiatric patients
More informationACTH therapy for generalized seizures other than spasms
Seizure (2006) 15, 469 475 www.elsevier.com/locate/yseiz ACTH therapy for generalized seizures other than spasms Akihisa Okumura a,b, *, Takeshi Tsuji b, Toru Kato b, Jun Natsume b, Tamiko Negoro b, Kazuyoshi
More informationAlthough the prevalence of epilepsy and
NEW-ONSET EPILEPSY IN WOMEN: AN INDICATION FOR A NEWER ANTIEPILEPTIC DRUG? Jeffrey Cohen, MD, PhD* ABSTRACT Seizure patterns are often related to the reproductive cycles of a woman with epilepsy. Seizures
More informationJulia B. Toub, MD. Providence Neuroscience Symposium November 29, 2018
Julia B. Toub, MD Providence Neuroscience Symposium November 29, 2018 I have no financial relationships to disclose. 1. Seizure: the clinical manifestation of an abnormal and excessive synchronization
More informationimproving the patient s quality of life.
Epilepsy is the tendency to have recurrent seizures unprovoked by systemic or acute neurologic insults. Antiepileptic drugs (AEDs) are those which decrease the frequency and/or severity of seizures in
More informationSeizures in Children: Laboratory
Article neurology Seizures in Children: Laboratory Diagnosis and Management Philippe Major, MD,* Elizabeth A. Thiele, MD, PhD* Objectives After completing this article, readers should be able to: 1. Formulate
More informationFebrile seizures. Olivier Dulac. Hôpital Necker-Enfants Malades, Université Paris V, INSERM U663
Febrile seizures Olivier Dulac Hôpital Necker-Enfants Malades, Université Paris V, INSERM U663 olivier.dulac@nck.aphp.fr Definition Seizures precipitated by fever that is not due to an intracranial infection
More informationSeizures and you. Michael B. Lloyd, MD
Seizures and you Michael B. Lloyd, MD Objectives Definition Epidemiology Classification Epileptic syndromes Differential and recognition Work-up Treatment Frequently asked questions Definition Sudden
More informationRetrospective study of topiramate in a paediatric population with intractable epilepsy showing promising effects in the West syndrome patients
Acta neurol. belg., 2000, 100, 171-176 Retrospective study of topiramate in a paediatric population with intractable epilepsy showing promising effects in the West syndrome patients J. THIJS, H. VERHELST,
More informationDr. Dafalla Ahmed Babiker Jazan University
Dr. Dafalla Ahmed Babiker Jazan University change in motor activity and/or behaviour due to abnormal electrical activity in the brain. seizures in children either - provoked by somatic disorders originating
More informationEpilepsy Martin J Brodie, Steven C Schachter, Patrick Kwan Fourth edition
Fast Facts Fast Facts: Epilepsy Martin J Brodie, Steven C Schachter, Patrick Kwan Fourth edition Fast Facts Fast Facts: Epilepsy Fourth edition Martin J Brodie MB ChB MRCP MD FRCP Director, Epilepsy Unit
More informationTo understand the formulary process from the hospital perspective
Formulary Process Michael A. Militello, Pharm.D. Cleveland Clinic Cleveland Clinic 2011 Goal and Objectives To understand the formulary process from the hospital perspective p To list the various panels
More informationEpilepsy for the General Internist
Epilepsy for the General Internist William O. Tatum DO, FAAN, FACNS Professor of Neurology Mayo College of Medicine Senior Consultant, Mayo Clinic Florida Director, Epilepsy Center and Monitoring Unit
More information2018 American Academy of Neurology
Practice Guideline Update Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment-Resistant Epilepsy Report by: Guideline Development, Dissemination, and Implementation Subcommittee of the
More informationWhen to start, which drugs and when to stop
When to start, which drugs and when to stop Dr. Suthida Yenjun, MD. PMK Epilepsy Annual Meeting 2016 The main factors to consider in making the decision The risk for recurrent seizures, which varies based
More informationThe epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care
The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care Issued: January 2012 last modified: January 2015 guidance.nice.org.uk/cg137 NICE has
More informationSODIUM CHANNEL BLOCKERS IN THE 21 ST CENTURY. Professor Martin J Brodie University of Glasgow Glasgow, Scotland
IN THE 21 ST CENTURY Professor Martin J Brodie University of Glasgow Glasgow, Scotland Eisai SODIUM CHANNEL BLOCKERS Declaration of interests UCB Pharma GlaxoSmithKline Lundbeck Takeda Advisory board,
More information